Towards precision medicine for anxiety disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugs

Anxiety disorders are increasingly prevalent, affect people’s ability to do things, and decrease quality of life. Due to lack of objective tests, they are underdiagnosed and sub-optimally treated, resulting in adverse life events and/or addictions. We endeavored to discover blood biomarkers for anxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Roseberry, K., Le-Niculescu, H., Levey, D. F., Bhagar, R., Soe, K., Rogers, J., Palkowitz, S., Pina, N., Anastasiadis, W. A., Gill, S. S., Kurian, S. M., Shekhar, A., Niculescu, A. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Immediate Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615756/
https://www.ncbi.nlm.nih.gov/pubmed/36878964
http://dx.doi.org/10.1038/s41380-023-01998-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615756/
https://www.ncbi.nlm.nih.gov/pubmed/36878964
http://dx.doi.org/10.1038/s41380-023-01998-0

Ejemplares similares